Explore genetic patterns related to glutamate-to-GABA conversion, excitatory receptor signaling, inhibitory signaling, neurotransmitter clearance, and neural-excitability regulation.
Feeling overstimulated does not necessarily mean you have “too much glutamate” or “not enough GABA.”
Two people can both struggle to calm down while having very different biological patterns:
Mutant evaluates these mechanisms as part of your overall genetic health analysis and ranks GABA- and glutamate-related hypotheses alongside findings from your other biological systems.
Start free. Your top 3 ranked health hypotheses across your entire analysis are included in full.
No new DNA test required. No credit card required.
A GABA- or glutamate-related hypothesis may or may not appear in your top 3, depending on your individual results.
If you experience patterns such as:
the useful question is not simply:
How can I increase GABA?
A better question may be:
Which part of my excitation-and-inhibition system deserves the most attention?
Mutant evaluates genetic context involving:
These findings provide genetic context. They do not measure current GABA or glutamate levels in the brain.
Mutant does not treat neural overactivation as one generic neurotransmitter imbalance.
Several different mechanisms can contribute to similar experiences.
Your brain may have less reserve for converting an activating neurotransmitter into an inhibitory one.
GABA is produced from glutamate through glutamate decarboxylase enzymes.
Important genes and pathways may include:
This does not establish a whole-brain GABA deficiency.
It describes a possible difference in GABA-production reserve, particularly when neural demand increases.
Active vitamin B6 is required for glutamate-to-GABA conversion, but a genetic pattern involving this pathway does not establish that vitamin B6 intake or blood levels are low.
The pathway also depends on:
A genetic finding in a B6-dependent pathway should not automatically be interpreted as a reason to take more vitamin B6.
A normal glutamate signal may produce a stronger or more persistent excitatory response.
Glutamate acts through several receptor families, including:
Relevant genetic context may involve pathways such as:
The issue is not necessarily excessive glutamate production.
A similar amount of glutamate can produce different effects depending on:
Rare pathogenic variants in glutamate-receptor genes can cause serious neurological disorders.
That is a different category from common susceptibility or regulatory variants used in a pattern-based analysis.
Mutant should not interpret a common SNP as equivalent to a rare disease-causing mutation.
GABA may be produced and released, but the inhibitory signal may not be received as reliably as expected.
GABA-A receptors are ion channels built from different combinations of subunits.
Relevant genetic context may include genes such as:
For inhibition to work properly, GABA must be:
A person can therefore have reasonable GABA synthesis while another part of inhibitory signaling has less reserve.
Common GABA-receptor variants should not be interpreted as an anxiety diagnosis or as a predictor of medication response.
GABA signaling may be terminated, recycled, or metabolized differently than expected.
After release, GABA must eventually be removed from the signaling space and recycled or metabolized.
Relevant pathways may include:
Faster or slower clearance is not automatically better or worse.
Healthy signaling requires the inhibitory signal to persist for an appropriate amount of time in the appropriate neural circuits.
Pathogenic variants in genes such as SLC6A1, ABAT, or ALDH5A1 can cause rare neurological disorders.
Those findings are not equivalent to common susceptibility variants and require a different level of interpretation and clinical confirmation.
Glutamate may be released normally but remain in the signaling environment longer when clearance reserve is limited.
Neurons are not responsible for glutamate handling alone.
Astrocytes play a major role in removing extracellular glutamate and recycling it through the glutamate-glutamine cycle.
Relevant pathways may include:
This is not necessarily excessive glutamate production.
The issue may instead involve how efficiently glutamate is removed and recycled after signaling.
These mechanisms can produce overlapping experiences.
For example, difficulty calming might reflect:
That is why Mutant evaluates GABA and glutamate findings as part of a larger systems model rather than as isolated SNP results.
Stress hormones and sympathetic activation can increase the amount of inhibitory control the nervous system needs.
This overlap may become more relevant when overstimulation includes:
Dopamine and norepinephrine contribute to attention, motivation, and mental activation.
For some people, activation improves focus until neural-excitability mechanisms make that activation difficult to regulate.
GABA/glutamate-related overstimulation may feel like generalized neural intensity.
Serotonin- and threat-related patterns may be more dominated by:
Both patterns can coexist.
Sleep loss can sharply reduce inhibitory reserve and sensory tolerance.
Circadian-related findings may be more relevant when activation is strongly linked to:
Histamine participates in wakefulness and immune signaling.
Histamine-related activation may overlap with:
DNA cannot directly tell you that your current brain GABA is low or your glutamate is high.
Neurotransmitter function depends on:
Even blood or urine neurotransmitter measurements should not automatically be interpreted as direct measures of neurotransmitter activity inside the brain.
Mutant therefore focuses on genetic susceptibility and pathway context, not claims about current neurotransmitter concentrations.
Mutant may evaluate genetic context involving:
These signals can contribute to ranked health hypotheses within your overall Mutant analysis.
The goal is not to diagnose anxiety, ADHD, epilepsy, autism, panic disorder, sensory-processing disorders, or another neurological or psychiatric condition.
The goal is to organize genetic susceptibility patterns and identify hypotheses worth exploring alongside actual health context.
Mutant Free lets you see what your overall analysis finds before deciding whether you want access to every hypothesis.
Included:
Your top 3 hypotheses may come from any biological system or hub.
A GABA- or glutamate-related hypothesis is included in full only if it ranks among those top 3.
No credit card required.
Mutant Full unlocks all remaining findings available from your analysis.
Included:
You can start free and upgrade at any time.
Mutant supports compatible genetic data from:
Mutant uses the same analysis framework regardless of DNA source.
The difference is genetic coverage.
Consumer DNA services measure selected genetic locations.
They may provide useful coverage for common variants involving:
Some markers used by Mutant may not be available.
A missing marker is treated as missing data, not as a normal result.
Whole-genome sequencing generally provides broader genetic coverage and may make additional variants available across:
WGS does not provide a different type of Mutant analysis.
It provides broader coverage for the same analysis framework.
Your complete raw DNA is not uploaded or stored by Mutant.
When you select supported DNA data:
Genetics cannot determine by itself why someone feels overstimulated or has difficulty calming.
Current neural function may also be influenced by:
Depending on the hypothesis, useful Health Context may include:
Mutant's Health Context helps identify information that may strengthen, weaken, or differentiate a ranked hypothesis.
GABA and glutamate pathways are frequent targets of supplement advice.
A genetic finding involving one of these pathways does not automatically establish a need for:
For example, vitamin B6 supports GABA synthesis, but more B6 is not automatically better. Excess supplemental vitamin B6 can cause neurological harm.
Likewise, an unusual response to a calming supplement does not prove that GABA or glutamate is high or low.
Genetic context should be interpreted alongside actual intake, symptoms, medications, health history, and other biological mechanisms.
Several medications affect GABA, glutamate, or related neural-excitability pathways.
Common genetic variants should not be used by themselves to determine:
Medication response depends on many factors beyond the neurotransmitter pathway itself.
Mutant is not a medication-selection test.
Genetic analysis should not replace appropriate neurological, psychiatric, sleep, or general medical evaluation.
Clinical review becomes particularly important with symptoms such as:
Rare pathogenic variants affecting GABA or glutamate pathways are also a different category from the common susceptibility patterns modeled in consumer genetic analysis.
Yes.
Compatible 23andMe data may contain common variants related to GABA production, glutamate receptors, GABA receptors, neurotransmitter transport, degradation, and glutamate clearance.
Coverage varies by testing version.
Learn About 23andMe Raw Data Analysis
Yes.
Compatible AncestryDNA data may also contain useful common variants.
Coverage is generally more limited than whole-genome sequencing.
Learn About AncestryDNA Analysis
No.
Your complete raw DNA is read locally in your browser.
Only the genetic markers required for your Mutant analysis are sent and retained.
No.
GABA regulation involves many genes controlling:
No single variant can determine brain GABA levels or whether a person has an anxiety or neurological condition.
No.
Glutamate biology involves:
No single variant can establish globally high or low glutamate.
No.
DNA can identify inherited tendencies involving GABA-related pathways.
It cannot directly measure current GABA signaling in specific brain circuits.
No.
A genetic analysis may identify patterns involving glutamate-receptor response or clearance reserve.
It cannot directly determine current glutamate concentrations in the brain.
Not by itself.
GAD1 is involved in the conversion of glutamate to GABA, but common variants generally act as modifiers rather than proving a clinically meaningful GABA deficiency.
Mutant evaluates GAD-related findings alongside other pathway signals.
Active vitamin B6 is required for glutamate decarboxylase activity.
That does not mean taking additional vitamin B6 will necessarily improve GABA signaling.
The pathway may not be B6-limited, and excessive supplementation can be harmful.
No.
Mutant identifies genetic susceptibility patterns involving neural excitation and inhibition.
Diagnosis requires appropriate clinical evaluation.
Not reliably from these common variants alone.
Medication effects depend on the specific drug, dose, metabolism, health conditions, other medications, and many other factors.
Free access is not assigned by hub.
Mutant Free includes your top 3 ranked health hypotheses across your entire analysis in full.
If a GABA- or glutamate-related hypothesis ranks among your top 3, you can explore it completely with Mutant Free.
Other hypotheses from this hub can still appear in your ranked findings, with full details available through Mutant Full.
Mutant Full unlocks all ranked hypotheses available from your analysis, including:
Mutant Full is $49/year.
No.
Mutant uses the same underlying analysis framework.
Free and Full determine how much of the resulting analysis you can open.
Whole-genome sequencing generally provides broader coverage than consumer genotyping data.
That can make more of the markers used by Mutant available.
It does not change the underlying type of Mutant analysis.
GABA and glutamate findings rarely exist in isolation.
Related Mutant analysis guides include:
These pages describe biological areas Mutant evaluates.
They are not separate free products. Mutant Free is based on your top 3 ranked hypotheses across your overall analysis.
Generic explanations such as “high glutamate” or “low GABA” can hide important differences in biology.
Mutant evaluates whether available genetic signals point toward:
These findings are ranked alongside the rest of your Mutant analysis.
Start free and see where GABA- and glutamate-related hypotheses rank in your results.
Your top 3 ranked health hypotheses are included in full. Mutant Full unlocks every remaining hypothesis.
No new DNA test required. No credit card required.
Your complete raw DNA stays in your browser.
Mutant provides educational and informational genetic analysis. Its findings are health hypotheses, not diagnoses, and are not a substitute for medical evaluation, clinical genetic testing, or treatment.